Citation: Ph. Cox, THE INTERNATIONAL-PHARMACEUTICAL-FEDERATION (FIP) SPECIAL INTEREST GROUP ON RADIOLOGIC PHARMACY, European journal of nuclear medicine, 25(2), 1998, pp. 213-214
Citation: R. Casadio et al., PERTURBATIONS IN THE KERR-NEWMAN DILATONIC BLACK-HOLE BACKGROUND - MAXWELL WAVES, Physical review. D. Particles and fields, 56(8), 1997, pp. 4948-4961
Citation: R. Casadio et al., NEW PERTURBATIVE SOLUTIONS OF THE KERR-NEWMAN DILATONIC BLACK-HOLE FIELD-EQUATIONS, Physical review. D. Particles and fields, 55(2), 1997, pp. 814-825
Citation: Ph. Cox, METABOLIC IMAGING USING F-18-FLUORODEOXYGLUCOSE TO ASSESS MYOCARDIAL VIABILITY - RESPONSE, International journal of cardiac imaging, 13(2), 1997, pp. 157-158
Citation: M. Pillay et al., TC-99M TETROFOSMIN MYOCARDIAL DISTRIBUTION 4 HOURS POST INJECTION, International journal of cardiac imaging, 12(2), 1996, pp. 127-135
Authors:
JONGENLAVRENCIC M
PEETERS HRM
ROZEMULLER H
ROMBOUTS WJC
MARTENS ACM
VREUGDENHIL G
PILLAY M
COX PH
BIJSER M
BRUTEL G
BREEDVELD FC
SWAAK AJG
Citation: M. Jongenlavrencic et al., IL-6-INDUCED ANEMIA IN RATS - POSSIBLE PATHOGENETIC IMPLICATIONS FOR ANEMIA OBSERVED IN CHRONIC INFLAMMATIONS, Clinical and experimental immunology, 103(2), 1996, pp. 328-334
Authors:
COX PH
FRIER M
FUEGER GF
STRAMPFER HG
HESSLEWOOD SR
Citation: Ph. Cox et al., 6TH EUROPEAN SYMPOSIUM ON RADIOPHARMACY AND RADIOPHARMACEUTICALS, GRAZ, AUSTRIA, 5-8 MARCH 1995, Nuclear medicine communications, 16(8), 1995, pp. 712-715
Citation: Ph. Cox, EEC DIRECTIVES AND GUIDELINES APPLICABLE TO RADIOPHARMACEUTICALS - 1993 - STATUS-QUO WITH PARTICULAR EMPHASIS ON THE REGISTRATION OF RADIOPHARMACEUTICALS WHICH WERE ON THE MARKET PRIOR TO JANUARY 1992, European journal of nuclear medicine, 20(8), 1993, pp. 712-715
Citation: Ph. Cox, CRITERIA FOR THE USE OF MONOCLONAL-ANTIBODIES, LEGISLATION AND ETHICAL CONSIDERATIONS, Nuclear medicine communications, 14(8), 1993, pp. 653-657